MMP13 and pancreatic neoplasm: In conclusion, this study elucidates the role of the IFN-γ/JAK/STAT1/CCL2/MMP13 pathway in exerting antitumor effects in pancreatic cancer by activating immune cells, which challenges the conventional understanding of CCL2 and MMP13 as promoters of tumor progression.